US President Donald Trump announced 25% tariffs on Indian exports to America, effective August 1. The biggest risk seen by ...

ArcelorMittal cut its forecast for steel demand and raised its estimate of the financial impact from US tariffs, which are ...

Major stock indexes have roared higher in recent weeks, but a survey of big investors shows lingering nervousness about the ...

U.S. President Donald Trump on Wednesday slapped 25% tariffs on Indian goods, along with an unspecified penalty tied to ...

Investors have plenty to parse, as they digest the impact of tariffs on corporate earnings and progress on trade deals. Ahead ...

Sensex and Nifty 50 recovered intraday losses to trade flat, lifted by gains in FMCG and private banking stocks. Bank Nifty ...

Textile manufacturers such as Welspun Living, Indo Count, Vardhman Textiles, Gokaldas Exports, Pearl Global and KPR Mills ...

The recently announced 25% tariff by the U.S. on Indian imports is expected to impact key export-driven sectors. According to ...

Amazon CEO Andy Jassy said much of what has been reported on the potential tariff impact on retail prices so far has been "noise" and "wrong," and said it was difficult to predict the ultimate impact.

Major players such as Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Divi’s Laboratories, Aurobindo Pharma, Lupin, and Biocon faced market volatility.

AbbVie said on Thursday its tariff exposure is not expected to exceed that of rivals, and raised its 2025 profit forecast ...